SOURCE: PHT Corporation

November 27, 2007 12:30 ET

PHT Expands Executive Roster to Support Continued Aggressive Growth in ePRO Industry

Appoints Vice Presidents of Development, Marketing at Boston Headquarters

BOSTON, MA--(Marketwire - November 27, 2007) - PHT Corporation continues its strong growth as the leader in the electronic patient reported outcome (ePRO) industry. PHT, the market-leading provider of ePRO solutions used in more than 330 clinical trials worldwide, today announced the appointment of Ian McLeod as Vice President of Development, and the promotion of Sheila Rocchio to Vice President of Marketing. Mr. McLeod and Ms. Rocchio are based at PHT's U.S. headquarters in Boston, MA, and report directly to PHT President and CEO Phil Lee.

Mr. McLeod's responsibilities include advancing technical development and vision by prioritizing the roadmap for new and expanded ePRO products and features. He is a Computer Engineering graduate of Lehigh University and holds a Masters of Engineering degree from Rensselaer Polytechnic Institute. Mr. McLeod has over 20 years of experience in leading large software development projects and organizations. Mr. McLeod previously was a Vice President at Borland Software, where he led the integration of Segue Software.

"I was attracted to PHT because it is at an inflection point with its tremendous growth and consistent positive earnings," said Mr. McLeod. "I look forward to working with PHT's talented team to continue the trend of balancing tactical support of current products with innovation for the ePRO industry as a whole."

During Ms. Rocchio's seven-year tenure at PHT, she has created the Product Management department and held global responsibilities for positioning, branding, communications and event management as PHT emerged as the clear ePRO market leader. Formerly the Executive Director of Marketing, Ms. Rocchio holds a Bachelor of Science from the Massachusetts Institute of Technology and an MBA from Boston College.

"Everyone at PHT has great enthusiasm and belief in our vision and mission," explained Ms. Rocchio. "The work we do has an invaluable impact on the lives of patients around the world. We play a critical role in the process of eradicating disease by enabling the collection of high quality data directly from patients, which yields faster and more conclusive trial results. It is an important time in the industry, and I look forward to helping PHT continue its impressive growth."

Mr. Lee said, "The creation of these two executive positions is a milestone in the growth and progress of PHT. Ian's experience and background successfully managing large-scale development initiatives are great assets as we advance the benefits and possibilities of ePRO. Sheila's knowledge of the eClinical market, our products and customer requirements further reinforces the value of our client-centric strategy. The Board and I welcome both professionals to their new roles, and we are excited for what the future holds."

About PHT Corporation

PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 330 clinical trials around the world. The company's proven LogPad® and StudyPad® Systems deliver the voice of the patient -- directly and without distortion -- with reliable and timely self-reported data. Patient experiences captured firsthand by PHT's ePRO Product Suite have been used successfully in at least eight NDA submissions, with five known approvals, to date. To learn more about how study sponsors worldwide are using ePRO to improve data quality, conduct smaller trials, and manage patient safety, enrollment and compliance in real time, visit www.phtcorp.com.

PHT, LogPad and StudyPad are among the registered trademarks and trademarks of PHT Corporation.

Contact Information